Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 29, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$20.5B
sum of reported positions
Reported positions
531
Changes vs prior quarter
432
75 new · 46 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 131 measured positions in 8 quarters, the typical new or larger position finished −4.2 pts against the S&P 500 and 46% finished ahead of it. For scale, across all 501 funds with a result: −2.1 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $14.7B | $20.5B |
| Positions | 502 | 531 |
| Biggest line | — | TEVA PHARMACEUTICAL INDS LTD 8% |
| 2.72M |
| $786M |
| 3.8% |
| 1.39M | $662M | 3.2% |
| 1.7M | $632M | 3.1% |
SELECT SECTOR SPDR TR | 3.24M | $599M | 2.9% |
| 2.28M | $594M | 2.9% |
SELECT SECTOR SPDR TR | 3.63M | $577M | 2.8% |
| 2.24M | $533M | 2.6% |
GLOBAL X FDS | 8.94M | $527M | 2.6% |
ISHARES TR | 743K | $476M | 2.3% |
| 836K | $471M | 2.3% |
| 1.47M | $442M | 2.2% |
GLOBAL X FDS | 6.99M | $418M | 2.0% |
| 371K | $375M | 1.8% |
| 986K | $373M | 1.8% |
| 2.23M | $363M | 1.8% |
| 300K | $353M | 1.7% |
ISHARES TR | 2.11M | $332M | 1.6% |
| 1.31M | $313M | 1.5% |
VANGUARD WORLD FD | 2.42M | $289M | 1.4% |
| 1.08M | $276M | 1.3% |
SELECT SECTOR SPDR TR | 1.4M | $266M | 1.3% |
TEVA PHARMACEUTICAL INDS LTD
46M → 48.1M shares (+5%)
Alphabet (GOOGL)
2.48M → 2.62M shares (+5%)
NVIDIA (NVDA)
4.08M → 4.42M shares (+8%)
Apple (AAPL)
2.32M → 2.72M shares (+17%)
Microsoft (MSFT)
1.36M → 1.7M shares (+25%)
SELECT SECTOR SPDR TR
2.93M → 3.24M shares (+10%)
Tower Semiconductor (TSEM)
1.99M → 2.28M shares (+15%)
SELECT SECTOR SPDR TR
2.84M → 3.63M shares (+28%)
Amazon (AMZN)
1.95M → 2.24M shares (+15%)
ISHARES TR
1,255 → 743K shares (+59082%)
Meta (META)
670K → 836K shares (+25%)
KLA Corporation (KLAC)
70 → 1.47M shares (+2093686%)
GLOBAL X FDS
4.65M → 6.99M shares (+51%)
Goldman Sachs (GS)
201K → 371K shares (+85%)
Broadcom (AVGO)
737K → 986K shares (+34%)
GE Vernova (GEV)
120 → 300K shares (+250040%)
ISHARES TR
34K → 2.11M shares (+6069%)
VANGUARD WORLD FD
305K → 2.42M shares (+693%)
Morgan Stanley (MS)
911 → 1.23M shares (+134400%)
Mongodb (MDB)
550K → 739K shares (+35%)
FIDELITY COVINGTON TRUST
3.15M → 3.56M shares (+13%)
FIRST TR EXCHANGE-TRADED FD
3.95M → 5.31M shares (+34%)
Etoro Group (ETOR)
1.99M → 5.86M shares (+195%)
Elbit Systems (ESLT)
270K → 275K shares (+2%)
GLOBAL X FDS
2.29M → 2.43M shares (+6%)
In its latest 13F, with holdings as of Jun 30, 2026 (Q2 2026), Harel Insurance Investments & Financial Services Ltd. reported 531 positions worth $20.5B. The largest: TEVA PHARMACEUTICAL INDS LTD, 8.0%; Nova (NVMI), 5.6%; Alphabet (GOOGL), 4.6%; NVIDIA (NVDA), 4.3%; Apple (AAPL), 3.8%. The five largest make up 26% of the reported portfolio.
TEVA PHARMACEUTICAL INDS LTD: $1.63B, or 8.0% of the portfolio reported for Q2 2026.
Between its last two 13F reports, Harel Insurance Investments & Financial Services Ltd. opened 75 new positions, added to 186, trimmed 125 and sold out of 46. The comparison is in share counts, so a price move alone does not count as buying or selling.
Its 13F for Q2 2026 adds up to $20.5B. That is not the whole firm: a 13F lists only US-listed shares and some options held at the end of the quarter, and leaves out cash, bonds, short positions and foreign holdings.
The report for Q2 2026 was filed on Jul 29, 2026. A manager has 45 days after the end of each quarter to file, so the holdings are always several weeks old when they become public.
On 131 positions it reported as new or larger over 8 quarters, the typical one finished −4.2 points against the S&P 500 after 90 days, and 46% finished ahead of it. Measured from the day each filing became public; history, not a forecast.
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.